Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Transplant Research and Risk Management is Scopus-indexed (Q3, CiteScore 1). Published by Dove Medical Press Ltd.
Checked against the index lists dated .
ISSN 1179-1616Verify ISSN ↗
Publisher: Dove Medical Press Ltd
Cost to publish: About US$1,806 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Transplantation | 40 / 55 | 28th | Q3 |
| Statistics, Probability and Uncertainty | 153 / 178 | 14th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–2024, best quartile Q3, CiteScore 1.
Transplant Research and Risk Management is Q3 in Transplantation (rank 40 of 55) and Q4 in Statistics, Probability and Uncertainty (rank 153 of 178), by CiteScore 2025.
Transplant Research and Risk Management is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1, quartile Q3, 28th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.209, quartile Q3, with an H-index of 8.
The publisher lists an article processing charge of about US$1,806 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Transplant Research and Risk Management is published by Dove Medical Press Ltd. Its ISSN is 1179-1616.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Transplant Research and Risk Management has an h-index of 11 and a 2-year mean of 1 citations per paper (OpenAlex). Its Scopus CiteScore is 1, quartile Q3. On 2-year citations it ranks #29 of 53 Scopus journals in Transplantation.
Transplant Research and Risk Management published 2 papers in 2024; its busiest recent year was 2019 with 8. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 12 research articles (2021–2024), authors are most often from United States (31.9%), Saudi Arabia (23.6%) and Israel (8.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.